Why partner with AstraZeneca?

We have a global commercial presence and strength in emerging markets, particularly in China. Our innovative medicines, many of which are developed in partnership with others, are used by millions of patients worldwide.



$24.4bn

Total Revenue

$819m

Collaboration Revenue

150+

major or strategically important deals completed in last three years

730+

collaborations worldwide help us access the best science, stimulate innovation and accelerate delivery of new medicines for unmet medical needs


70,600

employees

25

manufacturing sites in 16 countries

$6bn

invested in R&D

90%

of pipeline has a precision medicine approach


For year ending 31 December 2019
 


Pushing the boundaries of science to deliver life-changing medicines

Science is what drives AstraZeneca. We keep pushing the boundaries of science to deliver life-changing medicines that address significant unmet medical need in diseases affecting millions of people around the world.




Encouraging innovation and inspiring the next generation of start-ups



Veeva ID: Z4-27153
Date of Prep: Sept 2020